SIEGALL CLAY B 4
4 · Immunome Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-12-18$21.50/sh+46,511$999,987→ 853,247 total
Footnotes (1)
- [F1]The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.